-
Product Name
Lumiliximab (Synonyms: PRIMATIZED ANTI-CD23; GOMILIXIMAB [USAN])
- Documents
-
Description
Anti-FceR2 / CD23 Antibody (Lumiliximab)
-
Tested applications
ELISA
-
Species reactivity
Human FceR2 / CD23
-
Alternative names
PRIMATIZED ANTI-CD23 antibody; GOMILIXIMAB [USAN] antibody
-
Isotype
IgG1
-
Preparation
Recombinant expression and purified from CHO cells.
-
Clonality
Monoclonal
-
Formulation
0.1 M Pro-Ac, 20 mM Arg, pH 5.0
-
Storage instructions
-80°C for 2 years under sterile conditions; -20°C for 1 year under sterile conditions; Avoid repeated freeze-thaw cycles.
-
Validations
SDS-PAGE
Anti-FceR2 / CD23 Antibody (lumiliximab) on SDS-PAGE under reducing (R) condition. The purity of the protein is greater than 95%.
SEC-HPLC
The purity of Anti-FceR2 / CD23 Antibody (lumiliximab) is 100%, determined by SEC-HPLC.
Related Products / Services
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"